Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis

Neuroscience

Volumn 227, Issue , 2012, Pages 44-54

  Scofield, M D ^c   Korutla, L ^a   Jackson, T G ^a   Kalivas, P W ^c   Mackler, S A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ALS; Glutamate; Motor neuron; NAC1; TDP 43; UPS

Indexed keywords

GLUTAMIC ACID; NUCLEUS ACCUMBENS 1 PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CYTOPLASM; EMBRYO; FETUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOTONEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RAT; SPINAL CORD; SPINAL CORD NERVE CELL;

ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; CELL DEATH; CHOLINE O-ACETYLTRANSFERASE; CYTOPLASM; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; IMMUNOPRECIPITATION; NEOPLASM PROTEINS; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN BINDING; RATS; REPRESSOR PROTEINS; SPINAL CORD; TRANSFECTION; UBIQUITINATION;

EID: 84867743466     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.043     Document Type: Article

References (45)

1. Ahmad K.F., Melnick A., Lax S., Bouchard D., Liu J., Kiang C.L., Mayer S., Takahashi S., Licht J.D., Prive G.G. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell 2003, 12:1551-1564.
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006, 351:602-611.
3. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 2008, 121:3778-3785.
4. Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 2010, 30:639-649.
5. Bomont P., Cavalier L., Blondeau F., Ben Hamida C., Belal S., Tazir M., Demir E., Topaloglu H., Korinthenberg R., Tuysuz B., Landrieu P., Hentati F., Koenig M. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000, 26:370-374.
6. Brady O.A., Meng P., Zheng Y., Mao Y., Hu F. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J Neurochem 2010, 116:248-259.
7. Buratti E., Dork T., Zuccato E., Pagani F., Romano M., Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001, 20:1774-1784.
8. Cha X.Y., Pierce R.C., Kalivas P.W., Mackler S.A. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci 1997, 17:6864-6871.
9. Cohen T.J., Lee V.M., Trojanowski J.Q. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 2011, 17:659-667.
10. Darman J., Backovic S., Dike S., Maragakis N.J., Krishnan C., Rothstein J.D., Irani D.N., Kerr D.A. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci 2004, 24:7566-7575.
11. Fray A.E., Ince P.G., Banner S.J., Milton I.D., Usher P.A., Cookson M.R., Shaw P.J. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur J Neurosci 1998, 10:2481-2489.
12. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:438-458.
13. Hietanen M., Pelto-Huikko M., Rechardt L. Immunocytochemical study of the relations of acetylcholinesterase, enkephalin-, substance P-, choline acetyltransferase- and calcitonin gene-related peptide-immunoreactive structures in the ventral horn of rat spinal cord. Histochemistry 1990, 93:473-477.
14. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies. J Biol Chem 2009, 284:8516-8524.
15. Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S., Hasegawa M. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 2008, 582:2899-2904.
16. Kang M.I., Kobayashi A., Wakabayashi N., Kim S.G., Yamamoto M. Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci U S A 2004, 101:2046-2051.
17. Kim S.H., Shi Y., Hanson K.A., Williams L.M., Sakasai R., Bowler M.J., Tibbetts R.S. Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1. J Biol Chem 2009, 284:8083-8092.
18. Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 1998, 18:3241-3250.
19. Korutla L., Wang P., Jackson T.G., Mackler S.A. NAC1, a POZ/BTB protein that functions as a corepressor. Neurochem Int 2009, 54:245-252.
20. Korutla L., Wang P.J., Lewis D.M., Neustadter J.H., Stromberg M.F., Mackler S.A. Differences in expression, actions and cocaine regulation of two isoforms for the brain transcriptional regulator NAC1. Neuroscience 2002, 110:421-429.
21. Korutla L., Champtiaux N., Shen H.W., Klugmann M., Kalivas P.W., Mackler S.A. Activity-dependent subcellular localization of NAC1. Eur J Neurosci 2005, 22:397-403.
22. Kosuge Y., Sekikawa-Nishida K., Negi H., Ishige K., Ito Y. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice. Neurosci Lett 2009, 454:165-169.
23. Kreusch A., Pfaffinger P.J., Stevens C.F., Choe S. Crystal structure of the tetramerization domain of the Shaker potassium channel. Nature 1998, 392:945-948.
24. Liachko N.F., Guthrie C.R., Kraemer B.C. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci 2011, 30:16208-16219.
25. Maekawa S., Leigh P.N., King A., Jones E., Steele J.C., Bodi I., Shaw C.E., Hortobagyi T., Al-Sarraj S. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 2009, 29:672-683.
26. Melnick A.M., Adelson K., Licht J.D. The theoretical basis of transcriptional therapy of cancer: can it be put into practice?. J Clin Oncol 2005, 23:3957-3970.
27. Minor D.L., Lin Y.F., Mobley B.C., Avelar A., Jan Y.N., Jan L.Y., Berger J.M. The polar T1 interface is linked to conformational changes that open the voltage-gated potassium channel. Cell 2000, 102:657-670.
28. Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 2009, 10:232-246.
29. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 2009, 117:137-149.
30. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
31. Nonaka T., Arai T., Buratti E., Baralle F.E., Akiyama H., Hasegawa M. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett 2009, 583:394-400.
32. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995, 69:3584-3596.
33. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009, 65(Suppl. 1):S3-9.
34. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992, 326:1464-1468.
35. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 1993, 90:6591-6595.
36. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995, 38:73-84.
37. Sato T., Takeuchi S., Saito A., Ding W., Bamba H., Matsuura H., Hisa Y., Tooyama I., Urushitani M. Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons. Neuroscience 2009, 164:1565-1578.
38. Shan X., Vocadlo D., Krieger C. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS. Neurosci Lett 2009, 458:70-74.
39. Shaw P.J., Chinnery R.M., Ince P.G. [3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res 1994, 655:195-201.
40. Shen H., Korutla L., Champtiaux N., Toda S., LaLumiere R., Vallone J., Klugmann M., Blendy J.A., Mackler S.A., Kalivas P.W. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J Neurosci 2007, 27:8903-8913.
41. Stead M.A., Carr S.B., Wright S.C. Structure of the human Nac1 POZ domain. Acta Crystallogr Sect F Struct Biol Cryst Commun 2009, 65:445-449.
42. Urushitani M., Sato T., Bamba H., Hisa Y., Tooyama I. Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res 2010, 88:784-797.
43. Van Deerlin V.M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008, 7:409-416.
44. Wang J., Rao S., Chu J., Shen X., Levasseur D.N., Theunissen T.W., Orkin S.H. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444:364-368.
45. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 2009, 106:7607-7612.